T cell stemness and dysfunction in tumors are triggered by a common mechanism
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Stemness against adversity T lymphocytes are powerful immune cells that can destroy tumors, but cancers have developed tricks to evade killing. Vodnala et al. found that potassium ions in the tumor microenvironment serve a dual role of influencing T cell effector function and stemness (see the Perspective by Baixauli Celda et al. ). Increased potassium impairs T cell metabolism and nutrient uptake, resulting in a starvation state known as autophagy. The increased potassium can also preserve T cells in a stem-like state where they retain the capacity to divide. These seemingly divergent processes are linked to the cellular distribution of acetyl–coenzyme A, which, when manipulated, can restore the ability of human T cells to eliminate tumors in mice. Science , this issue p. eaau0135 ; see also p. 1395
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disabled autophagy due to progressive depletion of spermidine in aging tissues 233 can be expected to interfere with the immune recognition of cancer cells due the incapacity of dendritic cells to recognize autophagy-deficient cancer cells, as well as due to defective T lymphocyte and NK cell responses.163,252”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
Experimental — accuracy not yet measuredIn the citing paper
“This relies on cancer cell-autonomous effects but may also involve the autophagy-driven maintenance of a functional T cell memory stem cell pool, hence avoiding the exhaustion of the anticancer immune response.163”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
In the citing paper
“In addition, the extracellular release of potassium by dying cancer cells leads to the induction of autophagy in CD8+ T cells, thus resulting in the acquisition of a stem cell‐like phenotype and ultimately improving tumor clearance.”
From Autophagy in major human diseases (2021) · cites this paper as Vodnala et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823 · cited 2×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506 · cited 1×
“Nonetheless, the T cells of some patients maintain the capacity to proliferate, persist, and mediate the complete destruction of large tumor deposits (1).”
BackgroundSelf-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140 · cited 1×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 1×
“GSEA revealed that ↑[K]e conditioning resulted in a transcriptional profile that parallels the subset of CD8 T cells recently identified as retaining stemness and the capacity to respond to PD-1 therapy in the setting of chronic antigen exposure (15) (Fig.”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · cited 6×
“We and others have previously identified the transcription factor Tcf7 as being critically involved in the retention of stemcell–like attributes in antigen-experienced T cells (9, 11).”
BackgroundInfluential
Research works printed but not linked: 1
- H. Lodish A. Berk S. Zipursky in Molecular Cell Biology 4th Edition (2000) pp. 1–5.
Cited by
Items 101–200 of 559
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
Autophagy in tumor immune escape and immunotherapy
Wang, H., Sun, P., Yuan, X., Xu, Z., Jiang, X., Xiao, M., Yao, X., & Shi, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02277-y · Cited by 104
“Elevated K + levels trigger a starvation response in CD8 + T cells, reducing nutrient utilization and inducing autophagy, which in turn triggers T cell stemness [124].”
Boosting Checkpoint Immunotherapy with Biomaterials
Liu, L., Pan, Y., Zhao, C., Huang, P., Chen, X. S., & Rao, L. (2023) · ACS Nano · doi:10.1021/acsnano.2c11691 · Cited by 100
The diversity of CD8+ T cell dysfunction in cancer and viral infection
Galluzzi, L., Smith, K. N., Liston, A., & Garg, A. D. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01161-6 · Cited by 106
“…areas and tumour cores appear to promote profound CD8 + T cell dysfunction (potentially including senescence and cell death), at least partially through ionic and metabolic derangements that are elicited by accrued cancer cell death 220,221 , low oxygen levels 152 or cancer cell metabolism 222 .”
TCF-1: a maverick in T cell development and function
Gounari, F., & Khazaie, K. (2022) · Nature Immunology · doi:10.1038/s41590-022-01194-2 · Cited by 101
Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity
Jin, W., Xiao, L., Jeong, M., Han, S.-J., Zhang, W., Yano, H., Shi, H., Arifuzzaman, M., Lyu, M., Wang, D., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.029 · Cited by 102
Zhu, M., Han, Y., Gu, T., Wang, R. Y., Si, X., Kong, D., Zhao, P., Wang, X., Li, J., Zhai, X., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114065 · Cited by 98
Self-citationDNA Logic Circuits for Cancer Theranostics
Chen, J., Fu, S., Zhang, C., Liu, H., & Su, X. (2022) · Small · doi:10.1002/smll.202108008 · Cited by 98
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Titov, A., Valiullina, A., Zmievskaya, E., Zaikova, E. K., Petukhov, A., Рифкатовна, М. Р., Bulatov, E., & Rizvanov, A. A. (2020) · Cancers · doi:10.3390/cancers12010125 · Cited by 98
“The key mechanisms of tumor immunoevasion include: (1) impaired molecular trafficking into the tumor (caused by pro-tumoral endothelium [24,25], altered chemokine profile [26–28], and stiff stroma [29]); (2) microenvironment-mediated alterations that include hyperacidity and increased potassium level [30], presence of…”
BackgroundMetal ions and nanometallic materials in antitumor immunity: Function, application, and perspective
Shen, F., Fang, Y., Wu, Y., Zhou, M., Shen, J., & Fan, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01771-z · Cited by 94
“Recently, an increasing concentration of K+ in the TME has been proven to promote the persistence and stemness of tumor-infiltrating lymphocytes (TILs) through functional caloric restriction, which promotes autophagy and metabolic reprogramming [68].”
BackgroundWang, Z., Moresco, P., Yan, R., Li, J., Gao, Y., Biasci, D., Yao, M., Pearson, J., Hechtman, J. F., Janowitz, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119463119 · Cited by 93
A highly sensitive and selective nanosensor for near-infrared potassium imaging
Liu, J., Pan, L., Shang, C., Lu, B., Wu, R., Feng, Y., Chen, W., Zhang, R., Bu, J., Xiong, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax9757 · Cited by 85
Wu, Q., Tian, A.-L., Li, B., Leduc, M., Forveille, S., Hamley, P., Galloway, W., Xie, W., Liu, P., Zhao, L., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002722 · Cited by 83
Lv, T., Xiong, X., Yan, W., Liu, M., Xu, H., & He, Q. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004763 · Cited by 86
“The results”
Autophagy in the cancer-immunity dialogue
Yamazaki, T., Pedro, J. M. B., Galluzzi, L., Kroemer, G., & Pietrocola, F. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.003 · Cited by 86
Logic‐Gated Proximity Aptasensing for Cell‐Surface Real‐Time Monitoring of Apoptosis
Zheng, J., Wang, Q., Shi, L., Peng, P., Shi, L., & Li, T. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202106651 · Cited by 83
Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
Capatina, A. L., Lagos, D., & Brackenbury, W. J. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_46 · Cited by 86
Khouzam, R. A., Zaarour, R. F., Brodaczewska, K. K., Azakir, B., Venkatesh, G. H., Thiery, J., Terry, S., & Chouaïb, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828875 · Cited by 83
“CD8+ cells differentiation to cytotoxic T lymphocytes (80), their infiltrating and stemness preservation (81), T cells differentiation to Th cells, iNKT cells survival, differentiation and proliferation (82), DCs and B cells development (82), Treg cells survival, stability and immune tolerance (83), monocytes differen…”
BackgroundTillé, L., Cropp, D., Charmoy, M., Reichenbach, P., Andreatta, M., Wyss, T., Bodley, G., Crespo, I., Nassiri, S., Lourenço, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01614-x · Cited by 83
Hwang, K., Mou, Q., Lake, R. J., Xiong, M., Holland, B., & Lu, Y. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01280 · Cited by 82
Exploring the Role of ATP-Citrate Lyase in the Immune System
Dominguez, M., Brüne, B., & Namgaladze, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632526 · Cited by 75
“Intracellular acetyl-CoA levels have also been recently shown to regulate T cell fate in the context of the tumor microenvironment (107).”
BackgroundCortellino, S., Raveane, A., Chiodoni, C., Delfanti, G., Pisati, F., Spagnolo, V., Visco, E., Fragale, G., Ferrante, F., Magni, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111256 · Cited by 79
Rovatti, P. E., Gambacorta, V., Lorentino, F., Ciceri, F., & Vago, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00147 · Cited by 78
“The starvation response results in induction of autophagy and in epigenetic reprogramming, impairing T cell differentiation and function (80).”
BackgroundLópez-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2021.03.033 · Cited by 85
The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier
Pai, S. I., Cesano, A., & Marincola, F. M. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_6 · Cited by 81
“Furthermore, this can induce increased intracellular alkalosis in cancer cells and alteration of mitochondrial function leading to dysregulation of the ion concentration in the TME with its increasingly recognized effects on T cell function [74, 75].”
BackgroundExhausted T cells and epigenetic status
Zeng, Z., Wei, F., & Ren, X. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0338 · Cited by 78
Yu, W., Wang, Z., Yu, X., Zhao, Y., Xie, Z., Zhang, K., Chi, Z., Chen, S., Xu, T., Jiang, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31149-y · Cited by 74
Identifying metabolic limitations in the tumor microenvironment
Cognet, G., & Muir, A. (2024) · Science Advances · doi:10.1126/sciadv.adq7305 · Cited by 72
Metal Ion Signaling in Biomedicine
Rodriguez, R., Müller, S., Colombeau, L., Solier, S., Sindikubwabo, F., & Cañeque, T. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00577 · Cited by 76
Ma, S., Sandhoff, R., Luo, X., Shang, F., Shi, Q., Li, Z., Wu, J., Ming, Y., Schwarz, F., Madi, A., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adg8817 · Cited by 70
Autophagy in T Cell Function and Aging
Macian, F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00213 · Cited by 68
“Reduced cytosolic and nuclear content of acetyl coenzyme A caused changes in histone acetylation affecting programs of gene expression that eventually led to increased T cell stemness, decreased T cell exhaustion and, consequently, improved tumor control (Vodnala et al., 2019).”
BackgroundDietary Intervention Impacts Immune Cell Functions and Dynamics by Inducing Metabolic Rewiring
Okawa, T., Nagai, M., & Hase, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623989 · Cited by 63
“Similarly, in vitro culture of tumor-specificmemoryTcells underCRconditions enhancedantitumor functions, accompanied by the inactivation of mTOR signaling (57).”
BackgroundAdaptive immunity at the crossroads of autophagy and metabolism
Metur, S. P., & Klionsky, D. J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00662-3 · Cited by 70
Deng, S., Sun, Z., Qiao, J., Liang, Y., Liu, L., Dong, C., Shen, A., Wang, Y., Tang, H., Fu, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132000 · Cited by 70
“Recent studies have shown that maintaining CD8+ T cells in a self-renewed state could enhance persistence and antitumor function (83, 84).”
BackgroundThe effects of metabolism on the immune microenvironment in colorectal cancer
Chen, X., Ma, Z., Yi, Z., Wu, E., Shang, Z., Tuo, B., Li, T., & Liu, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01865-z · Cited by 71
“[19] In addition, reduced levels of glutamine induce the mRNA expression of EMT transcription factors (including zeb1, zeb2 and snail2).”
BackgroundSelf-citationPeng, H., Wu, X., Zhong, R., Tao, Y., Cai, X., Liu, J., Wen, Y., Ao, Y., Chen, J., Li, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750046 · Cited by 66
Chakraborty, P., Parikh, R. Y., Choi, S., Tran, D. T., Gooz, M. B., Hedley, Z. T., Kim, D., Pytel, D., Kang, I., Nadig, S. N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3155 · Cited by 67
Zhang, Y., Yeganeh, P. N., Zhang, H., Wang, S. Y., Li, Z., Gu, B., Lee, D.-J., Zhang, Z., Ploumakis, A., Shi, M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01932-8 · Cited by 67
“CD8 + T cells as a whole also downregulated Tcf7 , encoding TCF1, required for T cell stemness, memory formation and CD8 effector functions, and upregulated a large panel of coinhibitory receptor genes ( Pdcd1 (encoding PD-1), Lag3 , Cd244a , Tigit , Ctla4 , Cd160 ) 26,27 .”
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 70
Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 65
“233 In contrast, sodium chloride (NaCl) enhances the activation and effector functions of human CD8 + T cells, a process linked to improved metabolic fi tness.”
Self-citationT-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Chi, X., Luo, S., Ye, P., Hwang, W., Cha, J., Yan, X., & Yang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104771 · Cited by 67
Succinate preserves CD8+ T cell fitness to augment antitumor immunity
Ma, K., Cheng, H., Wang, L., Xiao, H., Liu, F., Yang, Y. T., Xiao, Z., Tang, K., Li, S., Wang, G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.017 · Cited by 65
Self-citationMetabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 62
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity
Soll, D., Chu, C.-F., Sun, S., Lutz, V., Arunkumar, M., Gachechiladze, M. A., Schäuble, S., Alissa-Alkhalaf, M., Nguyen, T. T. T., Khalil, M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01918-6 · Cited by 61
“Increased T cell effector functions, however, come at the expense of stemness and thus long-term maintenance of tumor antigen-or pathogen-specific memory T cells 3 .”
The epigenetic hallmarks of immune cells in cancer
Yu, J. H., Xiao, C., Fan, T. T., Deng, Z., Wang, D., Cai, W., Li, J., Liao, T., Li, C., & He, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02255-4 · Cited by 61
“Loss of acetylation fuels, including acetyl-CoA and ketones, leads to the deregulation of histone acetylation and impedes effector functions [134, 135].”
Liu, J., Liu, P., Xu, T., Chen, Z., Kong, H., Chu, W., Wang, Y., & Liu, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s239247 · Cited by 57
Peng, P., Wang, Q., Du, Y., Wang, H., Shi, L., & Li, T. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01612 · Cited by 57
Strategies for Dodging the Obstacles in CAR T Cell Therapy
Kozani, P. S., Kozani, P. S., Rahbarizadeh, F., & Nikkhoi, S. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627549 · Cited by 60
Promising Materials and Synthesis Methods for Resistive Switching Memory Devices: A Status Review
Kamble, G. U., Patil, A. P., Kamat, R. K., Kim, J. H., & Dongale, T. D. (2023) · ACS Applied Electronic Materials · doi:10.1021/acsaelm.3c00062 · Cited by 56
Sun, L., Kienzler, J. C., Reynoso, J. G., Lee, A., Shiuan, E. F., Li, S. J., Kim, J., Ding, L., Monteleone, A., Owens, G. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169314 · Cited by 57
“Interestingly, a recent paper demonstrated that pharmacologic treatment or gene therapies that induced a starvation response in antitumor T cells helped maintain their progenitor-like phenotype and resulted in enhanced killing of big, persistent tumors (63).”
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology
Pethő, Z., Najder, K., Carvalho, T. M. A., McMorrow, R., Todesca, L. M., Rugi, M., Bulk, E., Chan, A. B., Löwik, C. W. G. M., Reshkin, S. J., et al. (2020) · Cancers · doi:10.3390/cancers12092484 · Cited by 57
“melanoma (T lymphocyte) ↑ antitumor immunity in tumor-bearing mice [92,118]”
BackgroundIntratumoral CD8 + T cells with stem cell–like properties: Implications for cancer immunotherapy
Held, W., Siddiqui, I., Schaeuble, K., & Speiser, D. E. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay6863 · Cited by 58
Mo, J., Xu, Y., Wang, X., Wei, W., & Zhao, J. (2019) · Nanoscale · doi:10.1039/c9nr08570j · Cited by 55
Eosinophils in the Tumor Microenvironment
Mattei, F., Andreone, S., Marone, G., Gambardella, A. R., Loffredo, S., Varricchi, G., & Schiavoni, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_1 · Cited by 55
T cell metabolism in homeostasis and cancer immunity
Wei, J., Zheng, W., Chapman, N. M., Geiger, T. L., & Chi, H. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.02.003 · Cited by 59
“Although high levels of potassium in tumor tissues activate starvation response-associated mitochondrial metabolism that inhibits effector differentiation-associated epigenetic remodeling, potassium-stimulated tumor-infiltrating CD8+ T cells also acquire stemnessassociated programs that equip them with potent antitumo…”
BackgroundFueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Leone, R. D., & Powell, J. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0791 · Cited by 56
“Likewise, the inclusion of increased arginine or potassium in the culture media can promote the enhanced generation of long-lived memory cells (73, 74).”
BackgroundFatty acid metabolism in T-cell function and differentiation
Endo, Y., Kanno, T., & Nakajima, T. (2022) · International Immunology · doi:10.1093/intimm/dxac025 · Cited by 54
T cell-based cancer immunotherapy: opportunities and challenges
Ma, K., Xu, Y., Cheng, H., Tang, K., Ma, J., & Huang, B. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.03.054 · Cited by 53
Early methionine availability attenuates T cell exhaustion
Sharma, P., Guo, A., Poudel, S., Boada-Romero, E., Verbist, K., Palacios, G., Immadisetty, K., Chen, J., Haydar, D., Mishra, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02223-6 · Cited by 53
“38,39).”
The Role of Autophagy in Tumor Immunology—Complex Mechanisms That May Be Explored Therapeutically
de Souza, A. S. C., Gonçalves, L. B., Lepique, A. P., & de Araujo‐Souza, P. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.603661 · Cited by 54
“Furthermore, metabolic conditions of TME, such as elevated extracellular potassium levels, were responsible for autophagy activation on T-cells and boosted antitumor responses (62).”
BackgroundImmunometabolism – The Role of Branched-Chain Amino Acids
Yahsi, B., & Günaydın, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886822 · Cited by 51
Corria-Osorio, J., Carmona, S. J., Stefanidis, E., Andreatta, M., Ortiz-Miranda, Y., Muller, T., Rota, I. A., Crespo, I., Seijo, B., Castro, W., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01477-2 · Cited by 47
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Li, W., Pan, X., Chen, L., Cui, H., Mo, S., Pan, Y., Shen, Y., Shi, M., Wu, J., Luo, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186383 · Cited by 59
“histone deacetylase 6-specific inhibitor (HDAC6i) tubastatin A, combined with acetate (50), potassium supplement (141) and GSK-3b inhibitor (45), regulates epigenetic modification and has proven practical in ACT treatment.”
BackgroundBiometallic ions and derivatives: a new direction for cancer immunotherapy
Zhao, L., Gui, Y., Cai, J., & Deng, X. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02225-w · Cited by 52
“(C) Metal-ion-mediated immune-cell reprogramming [162].”
An effective mouse model for adoptive cancer immunotherapy targeting neoantigens
Hanada, K., Yu, Z., Chappell, G. R., Park, A. S., & Restifo, N. P. (2019) · JCI Insight · doi:10.1172/jci.insight.124405 · Cited by 52
Self-citationReece, A. S., & Hulse, G. K. (2019) · Epigenetics · doi:10.1080/15592294.2019.1633868 · Cited by 51
“[43] Vodnala SK, Eil R, Kishton RJ, et al.”
BackgroundImmunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 51
Imodoye, S. O., Adedokun, K. A., & Bello, I. O. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02258-6 · Cited by 50
“Recent work has also suggested that repurposing immunosuppressive drivers from the TME, such as increased potassium ion concentration (Vodnala et al. 2019) or cytokines such as IL-10 (Guo et al. 2021), may act to promote T-cell stemness or increase antitumor potency.”
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
Canedo, G. D. O., Roddie, C., & Amrolia, P. J. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013586 · Cited by 53
“…CD3 zeta domains with fewer immunoreceptor tyrosine-based activation motifs (ITAMs) 94 ; shortening the duration of ex vivo culture 83,95 ; using AKT inhibitors 96,97 ; or modifying the culture medium by including IL-21, 98 increasing the potassium concentration, 99 or adding N-acetylcysteine.”
Metabolic rewiring and communication in cancer immunity
Chapman, N. M., & Chi, H. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.001 · Cited by 48
“79 In contrast, CD8 + T cell stemness and anti-tumor function are improved when autophagy is engaged by exogenous potassium, 100 consistent with the notion that autophagy orchestrates the formation and mitochondrial fitness of memory CD8 + T cells.”
BackgroundWu, Y., Lu, W., Cui, Q.-R., Zhou, J., & Lu, G. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.06.002 · Cited by 55
Zhang, H., Li, S., Liu, S. M., Liao, Y., Liu, H., Yang, M., & Chen, P. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02491-8 · Cited by 52
Liu, S., Wu, J., Feng, Y., Guo, X., Li, T., Meng, M., Chen, J., Chen, D., & Tian, H. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.09.017 · Cited by 58
Potassium channels: Novel targets for tumor diagnosis and chemoresistance
Li, M., Tian, P., Zhao, Q. X., Ma, X., & Zhang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1074469 · Cited by 47
“In addition, potassium ions also play an important role in immunotherapy, and potassium ions are the key to controlling the anticancer ability of T cells (120).”
BackgroundTargeting the epigenome to reinvigorate T cells for cancer immunotherapy
Xiong, D., Zhang, L., & Sun, Z. (2023) · Military Medical Research · doi:10.1186/s40779-023-00496-2 · Cited by 51
“Interestingly, high level of extracellular potassium, despite suppressing T EFF programs by restricting nutrient uptake, induces histone deacetylation at the exhaustion loci and promote T cell stemness in the TIME [194].”
BackgroundDNA nanostructures for exploring cell–cell communication
Wang, Y., Xiong, Y., Shi, K., Effah, C. Y., Song, L., He, L., & Liu, J. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00944k · Cited by 49
Ong, S. T., Ng, A. S., Ng, X. R., Zhuang, Z., Wong, B. H. S., Prasannan, P., Kok, Y. J., Bi, X., Shim, H., Wulff, H., et al. (2019) · Bioelectricity · doi:10.1089/bioe.2019.0016 · Cited by 47
“10 A recent study shows that elevated levels of [K]e deplete cytoplasmic acetyl-coenzyme A to preserve epigenetic stemness.(18) The high-[K]e checkpoint is of fundamental physiological significance for many reasons.”
BackgroundSchrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 49
Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Manzoor, S., Muhammad, J. S., Maghazachi, A. A., & Hamid, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924290 · Cited by 45
STAT3 Role in T-Cell Memory Formation
Kaminskiy, Y., & Melenhorst, J. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052878 · Cited by 46
Calcium nanoparticles target and activate T cells to enhance anti-tumor function
Yang, W., Feng, Z., Lai, X., Li, J., Cao, Z., Jiang, F., Chen, F., Zhan, S., Kong, F., Yang, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54402-y · Cited by 44
“We have also included data on DCNP-Ab in subsequent in vivo data shown in Figure 4 Overall, both in vitro and in vivo data show that DCNP-Ab exhibits immunostimulatory effects, while PMA-loaded DCNP-Ab (PDCNP-Ab) performs better.”
Mechanism and role of regulated cell death in tumor immunity and immunotherapy
Hu, J., Li, Y., Lian, B., Mao, Y., & Zhao, L. (2025) · 癌症:英文版 · doi:10.1002/cac2.70064 · Cited by 45
“…potassium ion-mediated T-cell dysfunction in melanoma, where necrotic tumor cells inhibit CD4 + /CD8 + T-cell activity to block anti-tumor immunity [214]; reprogramming TAMs through RIPK1 inhibition, which shifts them toward an immunogenic phenotype to promote Th1/Th17 responses [215]; and…”
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 44
“At the same time, the reduction of methionine and its intermediates affects histone methylation and compromises the activation of signaling pathways involved in stemness suppression [293].”
BackgroundMa, L., Wang, X., Wu, Y., Zhang, Y., Yuan, X., Mao, J., Li, Q., & Gong, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.067 · Cited by 44
TCF-1 maintains CD8+ T cell stemness in tumor microenvironment
Wen, S., Lu, H., Wang, D., Guo, J., Dai, W., & Wang, Z. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr1120-778r · Cited by 46
Epigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 46
Chang, X., Tang, X., Liu, J., Zhu, Z., Mu, W., Tang, W., Zhang, Y., & Chen, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202303596 · Cited by 45
T cell-mediated curation and restructuring of tumor tissue coordinates an effective immune response
Hickey, J. W., Haist, M., Horowitz, N. B., Caraccio, C., Tan, Y., Rech, A. J., Baertsch, M., Rovira‐Clavé, X., Zhu, B., Vazquez, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113494 · Cited by 42
“Metabolic manipulation of T cells, 11 co-induced broad immune infiltration that shared borders with productive T cell and tumor neighborhoods.”
BackgroundThe Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 46
“Baixauli and Vodnala found that a high K+ concentration can trigger stem-cell-like characteristics in TILs, rendering them more effective in mediating tumor destruction following immune checkpoint inhibitor therapy [283,284].”
Self-citationUrolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity
Ma, S., Wu, Q., Wu, W., Tian, Y., Zhang, J., Chen, C., Sheng, X., Zhao, F., Ding, L., Wang, T., et al. (2024) · Advanced Science · doi:10.1002/advs.202310065 · Cited by 41
Immunotherapeutic strategies in head and neck cancer: challenges and opportunities
Liu, X., Harbison, R. A., Varvares, M. A., Puram, S. V., & Peng, G. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188128 · Cited by 45
Self-citationXiang, S., Zhan, H., Zhan, J., Li, X., Lin, X., & Sun, W. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100400 · Cited by 57
“However, by mitigating the hypoxic drive that contributes to exhaustion and potentially lowering the threshold for checkpoint blockade, OSNs can create a more permissive environment for reinvigorating these cells, especially when combined with immunotherapy (Vodnala et al., 2019).”
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 43
“Additional by-products, such as tumor-derived lactate and excess extracellular potassium, also regulate exhaustion by directly impairing effector function or skewing differentiation toward stem-like states [211 – 213].”
The multifaceted functions of cGAS
Liu, H., Wang, F., Cao, Y., Dang, Y., & Ge, B. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac031 · Cited by 44
Targeting dysregulated lipid metabolism in the tumor microenvironment
Kim, D., Song, N., & Yim, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01473-y · Cited by 44
“Recently, it has been increasingly emphasized that intracellular acetyl-CoA level in TME plays a vital role in regulating the fate of T cells (Vodnala et al. 2019).”
BackgroundHow metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
Acker, H. H. V., Ma, S., Scolaro, T., Kaech, S. M., & Mazzone, M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.03.006 · Cited by 41
“Furthermore, altered transmembrane potassium concentration and membrane potential has led to the functional caloric restriction in mouse CD8+ T cells is characterized by, among others, enhanced mitochondrial metabolism [56].”
BackgroundJia, Y., Xu, S., Han, G., Wang, B., Wang, Z., Lan, C., Zhao, P., Gao, M., Zhang, Y., Jiang, W., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00960-9 · Cited by 40
Xu, P., Ma, J., Zhou, Y. C., Gu, Y., Cheng, X., Wang, Y., Wang, Y., & Gao, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c10225 · Cited by 39
Peng, R., Huang, Q., Wang, L., Qiao, G., Huang, X., Jiang, J., & Chu, X. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202402715 · Cited by 42
Kim, T. H., Lim, S. H., Lee, H., Chae, Y. C., & Min, D. S. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01650-1 · Cited by 42
“Accumulated extracellular lactate inhibits T cell receptor signaling, prevents the nuclear translocation of NFAT, attenuates mTOR activity and induces intracellular acidi fi cation, collectively impairing T cell proliferation and effector cytokine release 84 .”
Metadata
- Authors
- Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., Palmer, D. C., Kruhlak, M. J., Liu, X., Locasale, J. W., Huang, J., Roychoudhuri, R., Finkel, T., Klebanoff, C. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Duke University (US)
- Babraham Institute (GB)
- University of Pittsburgh (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Vodnala, Suman Kumar
- Eil, Robert
- Restifo, Nicholas P.
- ORCID
- Vodnala, Suman Kumar
- Eil, Robert
- Kishton, Rigel J.
- Sukumar, Madhusudhanan
- Yamamoto, Tori N.
- Ha, Ngoc-Han
- Lee, Ping-Hsien
- Shin, MinHwa
- Patel, Shashank J.
- Yu, Zhiya
- Palmer, Douglas C.
- Kruhlak, Michael J.
- Liu, Xiaojing
- Locasale, Jason W.
- Huang, Jing
- Roychoudhuri, Rahul
- Finkel, Toren
- Klebanoff, Christopher A.
- Restifo, Nicholas P.
- Venue
- Science
- Published
- 2019-03-29
- Volume
- 363
- Issue
- 6434
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8194369
- OpenAlex
- W2924300946
- Cited by
- 552
- References
- 49
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 78 · 2023: 70 · 2022: 86 · 2021: 76 · 2020: 73 · 2019: 36
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (129832-RSG-16-214-01-TBE)
- National Cancer Institute (P30 CA008748)
- NIH Clinical Center
- Damon Runyon Cancer Research Foundation
- Parker Institute for Cancer Immunotherapy
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell stemness, T cell dysfunction, tumor microenvironment, potassium ions, T cell metabolism, nutrient uptake, autophagy, acetyl-CoA, T cell exhaustion, antitumor immunity, tumor immune evasion
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Autophagy, Cell Differentiation, Histones, Humans, Immune Tolerance, Lymphocyte Activation, Mice, Inbred C57BL, Neoplasms, Potassium, Stem Cells, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Caloric Restriction, Epigenesis, Genetic, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.